Group One Trading, L.P. Omeros Corp Transaction History

Group One Trading, L.P.

  • $2.68 Billion
  • Q2 2025

A detailed history of Group One Trading, L.P. transactions in Omeros Corp stock. As of the latest transaction made, Group One Trading, L.P. holds 118,989 shares of OMER stock, worth $497,374. This represents 0.01% of its overall portfolio holdings.

Number of Shares
118,989
Previous 29,567 302.44%
Holding current value
$497,374
Previous $243,000 46.5%
% of portfolio
0.01%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
$3.0 - $8.01 $268,266 - $716,270
89,422 Added 302.44%
118,989 $356,000
Q1 2025

May 14, 2025
SELL
$7.04 - $11.21 $476,960 - $759,477
-67,750 Reduced 69.62%
29,567 $243,000
Q4 2024

Feb 14, 2025
BUY
$3.77 - $12.15 $286,795 - $924,286
76,073 Added 358.09%
97,317 $961,000
Q3 2024

Nov 14, 2024
SELL
$3.54 - $5.47 $191,609 - $296,074
-54,127 Reduced 71.81%
21,244 $84,000
Q2 2024

Aug 14, 2024
SELL
$3.04 - $4.23 $109,096 - $151,802
-35,887 Reduced 32.26%
75,371 $306,000
Q1 2024

May 10, 2024
SELL
$2.88 - $4.89 $344,433 - $584,819
-119,595 Reduced 51.81%
111,258 $383,000
Q4 2023

Feb 14, 2024
BUY
$1.08 - $3.63 $9,886 - $33,229
9,154 Added 4.13%
230,853 $754,000
Q3 2023

Nov 09, 2023
BUY
$2.81 - $5.69 $530,238 - $1.07 Million
188,697 Added 571.77%
221,699 $647,000
Q2 2023

Aug 09, 2023
SELL
$4.45 - $7.57 $190,638 - $324,298
-42,840 Reduced 56.49%
33,002 $179,000
Q1 2023

May 12, 2023
BUY
$2.48 - $5.22 $141,895 - $298,667
57,216 Added 307.18%
75,842 $352,000
Q4 2022

Feb 09, 2023
BUY
$1.75 - $3.96 $10,423 - $23,585
5,956 Added 47.01%
18,626 $42,000
Q3 2022

Nov 09, 2022
BUY
$3.09 - $7.46 $39,150 - $94,518
12,670 New
12,670 $40,000
Q2 2022

Aug 11, 2022
SELL
$1.92 - $6.28 $183,982 - $601,774
-95,824 Closed
0 $0
Q1 2022

May 12, 2022
SELL
$5.07 - $7.2 $906,622 - $1.29 Million
-178,821 Reduced 65.11%
95,824 $576,000
Q4 2021

Feb 11, 2022
BUY
$5.67 - $8.54 $459,440 - $691,996
81,030 Added 41.85%
274,645 $1.77 Million
Q3 2021

Nov 12, 2021
BUY
$13.4 - $16.3 $412,385 - $501,632
30,775 Added 18.9%
193,615 $2.67 Million
Q2 2021

Aug 10, 2021
SELL
$14.81 - $19.13 $154,112 - $199,066
-10,406 Reduced 6.01%
162,840 $2.42 Million
Q1 2021

May 12, 2021
SELL
$14.52 - $23.53 $461,343 - $747,618
-31,773 Reduced 15.5%
173,246 $3.08 Million
Q4 2020

Feb 10, 2021
SELL
$10.14 - $15.19 $302,395 - $452,996
-29,822 Reduced 12.7%
205,019 $2.93 Million
Q3 2020

Nov 12, 2020
BUY
$9.57 - $21.32 $2.09 Million - $4.65 Million
218,112 Added 1303.8%
234,841 $2.37 Million
Q2 2020

Aug 13, 2020
BUY
$12.21 - $16.99 $204,261 - $284,225
16,729 New
16,729 $246,000
Q1 2020

May 13, 2020
SELL
$9.03 - $19.72 $614,238 - $1.34 Million
-68,022 Closed
0 $0
Q4 2019

Feb 10, 2020
BUY
$13.01 - $17.15 $23,404 - $30,852
1,799 Added 2.72%
68,022 $958,000
Q3 2019

Nov 12, 2019
BUY
$14.55 - $20.56 $496,737 - $701,918
34,140 Added 106.41%
66,223 $1.08 Million
Q2 2019

Aug 09, 2019
SELL
$15.0 - $19.62 $182,595 - $238,834
-12,173 Reduced 27.51%
32,083 $503,000
Q1 2019

May 13, 2019
SELL
$11.65 - $17.72 $191,759 - $291,671
-16,460 Reduced 27.11%
44,256 $769,000
Q4 2018

Feb 06, 2019
BUY
$10.72 - $16.73 $164,841 - $257,257
15,377 Added 33.92%
60,716 $676,000
Q3 2018

Nov 08, 2018
BUY
$17.73 - $26.69 $803,860 - $1.21 Million
45,339 New
45,339 $1.11 Million
Q1 2018

May 11, 2018
SELL
$9.0 - $20.16 $1.36 Million - $3.04 Million
-150,913 Closed
0 $0
Q4 2017

Feb 09, 2018
BUY
$13.26 - $22.86 $940,120 - $1.62 Million
70,899 Added 88.61%
150,913 $2.93 Million
Q3 2017

Nov 15, 2017
BUY
$19.76 - $24.9 $1.58 Million - $1.99 Million
80,014
80,014 $1.73 Million

Others Institutions Holding OMER

# of Institutions
141
Shares Held
29.8M
Call Options Held
364K
Put Options Held
1.21M
View Full List

About OMEROS CORP

OMER Quotes by TradingView
  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $262M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email